Kevin Shee, MD, PhD
Resident
Urology
School of Medicine

Publications (49)

Top publication keywords:
Triple Negative Breast NeoplasmsHyperoxaluria, PrimaryBreast DiseasesOxalatesBreast NeoplasmsHyperoxaluriaCarcinoma, Intraductal, NoninfiltratingRobotic Surgical ProceduresReceptors, EstrogenKidney Failure, ChronicBiomarkers, Tumorfms-Like Tyrosine Kinase 3Bone Morphogenetic Protein 4UrologyDrug Resistance, Neoplasm

• The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort.
  European urology oncology 2023 Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR
• Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes.
  European urology oncology 2023 Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR
• The Fate of Residual Fragments After Percutaneous Nephrolithotomy: Results from the Endourologic Disease Group for Excellence Research Consortium.
  Journal of endourology 2023 Wong VKF, Que J, Kong EK, Abedi G, Nimmagadda N, Emmott AS, Paterson RF, Lange D, Lundeen CJ, Nevo A, Shee K, Moore J, Pais V, Sur RL, Bechis SK, Miller NL, Hsi R, Knudsen BE, Sourial M, Humphreys MR,…
• Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging.
  The Journal of urology 2023 Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carroll PR, Cooperberg MR
• Voided volume may not impact stone outcomes: Review of a large institutional nephrolithiasis cohort.
  BJUI compass 2023 Shee K, Chan C, Yang H, Sui W, Bowman M, Hamouche F, Charondo LB, Ho S, Chi T, Stoller ML

Show all (44 more) Hide

• Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort.
  European urology 2023 Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• The endoplasmic reticulum stress response in prostate cancer.
  Nature reviews. Urology 2022 de la Calle CM, Shee K, Yang H, Lonergan PE, Nguyen HG
• Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort.
  The Journal of urology 2022 Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR
• Identifying Barriers to Successful Completion of Video Telemedicine Visits in Urology.
  Urology 2022 Shee K, Liu AW, Yarbrough C, Branagan L, Pierce L, Odisho AY
• Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial.
  Advances in radiation oncology 2022 Shee K, de la Calle CM, Chang AJ, Wong AC, Feng FY, Gottschalk AR, Carroll PR, Nguyen HG
• Perspectives in primary hyperoxaluria - historical, current and future clinical interventions.
  Nature reviews. Urology 2021 Shee K, Stoller ML
• Formal Mentorship as an Opportunity to Expand the Urology Pipeline: Under Represented Trainees Entering Residency (UReTER) Program Evaluation 2020-2021.
  Urology 2021 Zheng MY, Overland M, Escobar D, Fakunle M, Li Y, Chu C, Balakrishnan A, Shee K, Washington S, Hampson L
• Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer.
  JCO clinical cancer informatics 2021 Shee K, Pal SK, Wells JC, Ruiz-Morales JM, Russell K, Dudani S, Choueiri TK, Heng DY, Gore JL, Odisho AY
• Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance.
  Urology 2021 de la Calle CM, Shee K, Chu CE, Cowan JE, Nguyen HG, Carroll PR
• Nedosiran Dramatically Reduces Serum Oxalate in Dialysis-Dependent Primary Hyperoxaluria 1: A Compassionate Use Case Report.
  Urology 2021 Shee K, Ahn J, Hamouche F, Mena J, Chi T, Stoller ML
• Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant.
  The oncologist 2021 Schwartz G, Shee K, Romo B, Marotti J, Kisselev A, Lewis L, Miller T
• Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Axelrod ML, Nixon MJ, Gonzalez-Ericsson PI, Bergman RE, Pilkinton MA, McDonnell WJ, Sanchez V, Opalenik SR, Loi S, Zhou J, Mackay S, Rexer BN, Abramson VG, Jansen VM, Mallal S, Donaldson J, Tolaney SM…
• A rare initial diagnosis of cystinuria during pregnancy.
  Clinical nephrology 2020 Shee K, Pais V
• Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma.
  Journal of neuro-oncology 2020 Shee K, Chambers M, Hughes EG, Almiron DA, Deharvengt SJ, Green D, Lefferts JA, Andrew AS, Hickey WF, Tsongalis GJ
• Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer.
  Breast cancer research and treatment 2020 Chamberlin MD, Wells JD, Shee K, Bean JR, Marotti JD, Wells WA, Trask HW, Kolling FW, Bhatt A, Kaufman PA, Schwartz GN, Gemery JM, McNulty NJ, Tsapakos MJ, Barth RJ, Arrick BA, Gui J, Miller TW
• AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Hampsch RA, Wells JD, Traphagen NA, McCleery CF, Fields JL, Shee K, Dillon LM, Pooler DB, Lewis LD, Demidenko E, Huang YH, Marotti JD, Goen AE, Kinlaw WB, Miller TW
• Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer.
  Cancer biomarkers : section A of Disease markers 2020 Shee K, Seigne JD, Karagas MR, Marsit CJ, Hinds JW, Schned AR, Pettus JR, Armstrong DA, Miller TW, Andrew AS
• Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy.
  PloS one 2019 Shee K, Wells JD, Jiang A, Miller TW
• A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Shee K, Wells JD, Ung M, Hampsch RA, Traphagen NA, Yang W, Liu SC, Zeldenrust MA, Wang L, Kalari KR, Yu J, Boughey JC, Demidenko E, Kettenbach AN, Cheng C, Goetz MP, Miller TW
• Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer.
  Molecular oncology 2019 Hosford SR, Shee K, Wells JD, Traphagen NA, Fields JL, Hampsch RA, Kettenbach AN, Demidenko E, Miller TW
• Calcifications mimicking ductal carcinoma in situ in a patient with end-stage renal disease.
  The breast journal 2019 Shee K, Veilleux LW, Linos K, Marotti JD
• Biomarkers to diagnose metastatic breast carcinoma to the pancreas: A case report and update.
  Diagnostic cytopathology 2019 Shee K, Strait AM, Liu X
• Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer Cells.
  Cell biochemistry and biophysics 2019 Mast JM, Tse D, Shee K, Lakshmi Kuppusamy M, Kmiec MM, Kálai T, Kuppusamy P
• A novel ex vivo trainer for robotic vesicourethral anastomosis.
  Journal of robotic surgery 2019 Shee K, Koo K, Wu X, Ghali FM, Halter RJ, Hyams ES
• Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing.
  The American journal of pathology 2018 Shee K, Muller KE, Marotti J, Miller TW, Wells WA, Tsongalis GJ
• Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer.
  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018 Shee K, Jiang A, Varn FS, Liu S, Traphagen NA, Owens P, Ma CX, Hoog J, Cheng C, Golub TR, Straussman R, Miller TW
• Following the crowd: patterns of crowdsourcing on Twitter among urologists.
  World journal of urology 2018 Koo K, Shee K, Gormley EA
• Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer.
  The Journal of experimental medicine 2018 Shee K, Yang W, Hinds JW, Hampsch RA, Varn FS, Traphagen NA, Patel K, Cheng C, Jenkins NP, Kettenbach AN, Demidenko E, Owens P, Faber AC, Golub TR, Straussman R, Miller TW
• The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53.
  The Journal of biological chemistry 2018 Madan E, Parker TM, Bauer MR, Dhiman A, Pelham CJ, Nagane M, Kuppusamy ML, Holmes M, Holmes TR, Shaik K, Shee K, Kiparoidze S, Smith SD, Park YA, Gomm JJ, Jones LJ, Tomás AR, Cunha AC, Selvendiran K, …
• Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancer.
  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018 Yang W, Hosford SR, Traphagen NA, Shee K, Demidenko E, Liu S, Miller TW
• Trailblazing Precision Oncology for Rare Tumor Subtypes.
  The oncologist 2017 Shee K, Miller TW
• Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.
  Science (New York, N.Y.) 2017 Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, …
• Pain Management in Penile Prosthetic Surgery: A Review of the Literature.
  Sexual medicine reviews 2017 Reinstatler L, Shee K, Gross MS
• Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer.
  Oncotarget 2017 Hampsch RA, Shee K, Bates D, Lewis LD, Désiré L, Leblond B, Demidenko E, Stefan K, Huang YH, Miller TW
• Practice Makes Perfect: Correlations Between Prior Experience in High-level Athletics and Robotic Surgical Performance Do Not Persist After Task Repetition.
  Journal of surgical education 2017 Shee K, Ghali FM, Hyams ES
• News Media Analysis of the United States Preventive Services Task Force and American Urological Association Prostate Cancer Screening Guidelines.
  Urology practice 2016 Koo K, Shee K, Yap RL
• Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin.
  Case reports in oncology 2016 Shee K, Kono AT, D'Anna SP, Seltzer MA, Lu X, Miller TW, Chamberlin MD
• Readability analysis of online health information about overactive bladder.
  Neurourology and urodynamics 2016 Koo K, Shee K, Yap RL
• Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury.
  Neuroscience letters 2016 Shee K, Lucas A, Flashman LA, Nho K, Tsongalis GJ, McDonald BC, Saykin AJ, McAllister TW, Rhodes CH
• Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Yang W, Hosford SR, Dillon LM, Shee K, Liu SC, Bean JR, Salphati L, Pang J, Zhang X, Nannini MA, Demidenko E, Bates D, Lewis LD, Marotti JD, Eastman AR, Miller TW
• Cell Competition During Growth and Regeneration.
  Annual review of genetics 2015 Gogna R, Shee K, Moreno E
• The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.
  Breast cancer research and treatment 2014 Bean JR, Hosford SR, Symonds LK, Owens P, Dillon LM, Yang W, Shee K, Schwartz GN, Marotti JD, Muller KE, Rosenkranz KM, Barth RJ, Chen VS, Agarwal VR, Miller TW
• Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
  Nature 2012 Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR
• Research, collaboration, and open science using web 2.0.
  Journal of microbiology & biology education 2010 Shee K, Strong M, Guido NJ, Lue RA, Church GM, Viel A